MiMedx Group Inc (MDXG)
7.185
-0.18
(-2.51%)
USD |
NASDAQ |
May 06, 13:46
MiMedx Group Cash from Financing (Quarterly): -33.47M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -33.47M |
| December 31, 2023 | -8.94M |
| September 30, 2023 | 0.37M |
| June 30, 2023 | 0.004M |
| March 31, 2023 | -0.004M |
| December 31, 2022 | 0.066M |
| September 30, 2022 | 0.13M |
| June 30, 2022 | 0.26M |
| March 31, 2022 | -1.036M |
| December 31, 2021 | 0.022M |
| September 30, 2021 | -0.15M |
| June 30, 2021 | -0.916M |
| March 31, 2021 | -2.308M |
| December 31, 2020 | -1.243M |
| September 30, 2020 | 66.73M |
| June 30, 2020 | -1.753M |
| March 31, 2020 | -2.177M |
| December 31, 2019 | -1.138M |
| September 30, 2019 | -1.707M |
| June 30, 2019 | 66.75M |
| March 31, 2019 | -1.044M |
| December 31, 2018 | -0.285M |
| September 30, 2018 | -0.224M |
| June 30, 2018 | -0.334M |
| March 31, 2018 | -8.091M |
| Date | Value |
|---|---|
| December 31, 2017 | -24.59M |
| September 30, 2017 | -27.57M |
| June 30, 2017 | 4.905M |
| March 31, 2017 | -13.14M |
| December 31, 2016 | 0.698M |
| September 30, 2016 | -6.576M |
| June 30, 2016 | 0.833M |
| March 31, 2016 | -3.106M |
| December 31, 2015 | -18.54M |
| September 30, 2015 | -3.731M |
| June 30, 2015 | -2.911M |
| March 31, 2015 | -11.05M |
| December 31, 2014 | 0.889M |
| September 30, 2014 | -0.068M |
| June 30, 2014 | -4.154M |
| March 31, 2014 | 1.187M |
| December 31, 2013 | 37.67M |
| September 30, 2013 | 1.279M |
| June 30, 2013 | 0.5459M |
| March 31, 2013 | 1.142M |
| December 31, 2012 | 0.2381M |
| September 30, 2012 | 5.992M |
| June 30, 2012 | 0.136M |
| March 31, 2012 | 0.2437M |
| December 31, 2011 | 4.949M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-33.47M
Minimum
Mar 2024
66.75M
Maximum
Jun 2019
3.975M
Average
-0.533M
Median
Cash from Financing (Quarterly) Benchmarks
| TELA Bio Inc | 0.022M |
| Amylyx Pharmaceuticals Inc | 0.23M |
| CEL-SCI Corp | 4.048M |
| AIM ImmunoTech Inc | 0.147M |
| IGC Pharma Inc | -0.001M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.978M |
| Cash from Investing (Quarterly) | -6.024M |
| Free Cash Flow | 29.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0011 |
| Free Cash Flow to Equity (Quarterly) | 28.48M |
| Free Cash Flow to Firm (Quarterly) | 1.176M |
| Free Cash Flow Yield | 3.07% |